Wenxiu Xin

1 East Banshan Road
Hangzhou, 310022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Mitochondrial fission-mediated podocyte dysfunction via CaMKII/Drp1 signaling pathways contributes to lenvatinib-induced renal injury.

Mitochondrial fission-mediated podocyte dysfunction via CaMKII/Drp1 signaling pathways contributes to lenvatinib-induced renal injury.

Journal: Biochemical pharmacology
Published: April 30, 2026

Sarcandra glabra: phytochemistry, pharmacological activities, and its role in mucosal immunity and digestive diseases.

Sarcandra glabra: phytochemistry, pharmacological activities, and its role in mucosal immunity and digestive diseases.

Journal: Frontiers in immunology
Published: April 09, 2026

Metabolic heterogeneity and functional diversity of cancer-associated fibroblasts in gastric cancer (Review).

Metabolic heterogeneity and functional diversity of cancer-associated fibroblasts in gastric cancer (Review).

Journal: Oncology letters
Published: April 02, 2026

MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination.

MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination.

Journal: International immunopharmacology
Published: November 29, 2025

Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1.

Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1.

Journal: Toxicology and applied pharmacology
Published: September 17, 2025

Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death.

Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death.

Journal: Cell communication and signaling : CCS
Published: September 08, 2025

Isoliquiritigenin suppresses fatty acid synthesis and cancer cell migration in anaplastic thyroid carcinoma through AMPK/SREBF1 pathway.

Isoliquiritigenin suppresses fatty acid synthesis and cancer cell migration in anaplastic thyroid carcinoma through AMPK/SREBF1 pathway.

Journal: Archives of biochemistry and biophysics
Published: January 06, 2025

miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition.

miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition.

Journal: Molecular carcinogenesis
Published: November 19, 2024

CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer.

CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer.

Journal: PloS one
Published: August 11, 2024

Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer.

Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer.

Journal: BMJ open
Published: July 13, 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study.

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study.

Journal: Expert opinion on drug safety
Published: May 16, 2024

Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Journal: European journal of clinical pharmacology
Published: April 02, 2024
Showing 1-12 of 46

Last Updated: 09/26/2026